Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows a minor update: Revision v3.4.2 was added and Revision v3.4.1 was removed. This update affects only metadata and does not alter study content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedPlatform revision from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedUI and labeling updates include adding a glossary toggle, and capitalization/wording changes such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the version tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section has been reorganized: a single Locations heading now appears with the participating states (California, Connecticut, Florida, Georgia, Louisiana, Maryland, New York, North Carolina, Ohio, Pennsylvania, Washington), and per-state 'Locations' subsections were removed.SummaryDifference1%

- Check91 days agoChange DetectedPublications section wording updated to state PubMed-sourced publications are automatically filled, with a new revision note (v3.3.2). The previous description about PubMed data and automatic listing by NCT number has been revised (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.